Bonfire97 said:
Quote:
As far as I know, there is evidence that suggests that higher intensity regimens to decrease risk of recurrent major cardiac events
The one thing to point out is that statins do not reduce heart attack or all cause mortality risk anywhere near what they are advertised. They "lie" with statistics because they list relative risk reduction as opposed to absolute risk reduction. For instance, with Rosuvastatin, the trial showed an actual event reduction of 2.8% placebo vs 1.6% control. That's 1.2% or 1.2 people of 100. However, they claim a 44% reduction looking at the difference between 2.8 to 1.6. All drug companies advertise like this and it's really criminal.
Well, no, they do reduce it to what they're advertised, the issue is that the average person doesn't understand statistics enough to realize that relative risk reduction is used instead of absolute risk reduction. And while some doctors aren't that good with statistics, more and more med schools are increasing statistics in their curriculum. But the real issue here is advertising directly to the public. People go to their doctor and want that drug that reduces their risk by 44%, regardless of what the doctor tries to tell them. Just like they want ivermectin, or hydroxychloroquine
If someone has a heart attack on low intensity therapy, do you think a courtroom is going to care that the doctor was looking at ARR when deciding not to maximize an individual's risk reduction? I guarantee you any lawyer worth his salt can get 100 expert witnesses to say that the patient was not on optimal medications for maximal risk reduction. The practice of medicine these days is becoming more and more on what is defensible in court.